EP4713331A1 - Neue kristalline form von risdiplam und herstellungsverfahren dafür - Google Patents

Neue kristalline form von risdiplam und herstellungsverfahren dafür

Info

Publication number
EP4713331A1
EP4713331A1 EP24806796.9A EP24806796A EP4713331A1 EP 4713331 A1 EP4713331 A1 EP 4713331A1 EP 24806796 A EP24806796 A EP 24806796A EP 4713331 A1 EP4713331 A1 EP 4713331A1
Authority
EP
European Patent Office
Prior art keywords
risdiplam
crystalline form
crystalline
preparation
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24806796.9A
Other languages
English (en)
French (fr)
Inventor
Nitin Sharadchandra Pradhan
Vihar Raghunath Telange
Yuvaraj Suresh SONAR
Vaibhav Chandrakant SHINDE
Harpreet Singh Minhas
Gurpreet Singh Minhas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harman Finochem Ltd
Original Assignee
Harman Finochem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harman Finochem Ltd filed Critical Harman Finochem Ltd
Publication of EP4713331A1 publication Critical patent/EP4713331A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP24806796.9A 2023-05-13 2024-04-30 Neue kristalline form von risdiplam und herstellungsverfahren dafür Pending EP4713331A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202321033768 2023-05-13
PCT/IN2024/050457 WO2024236590A1 (en) 2023-05-13 2024-04-30 Novel crystalline form of risdiplam and process for preparation thereof

Publications (1)

Publication Number Publication Date
EP4713331A1 true EP4713331A1 (de) 2026-03-25

Family

ID=93518766

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24806796.9A Pending EP4713331A1 (de) 2023-05-13 2024-04-30 Neue kristalline form von risdiplam und herstellungsverfahren dafür

Country Status (4)

Country Link
EP (1) EP4713331A1 (de)
CN (1) CN121399140A (de)
IL (1) IL324578A (de)
WO (1) WO2024236590A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20251594T1 (hr) * 2017-09-22 2026-01-30 F. Hoffmann - La Roche Ag Postupak priprave derivata 7-(4,7-diazaspiro[2.5]oktan-7-il)-2-(2,8-dimetilimidazo[1,2-b]piridazin-6-il)pirido[1,2-a]pirimidin-4-ona
IL319888A (en) * 2018-10-19 2025-05-01 Hoffmann La Roche Forms of pyrido[2,1-A]pyrimidin-4-one derivatives, their formulations and process for their preparation
EP4004003A1 (de) * 2019-07-31 2022-06-01 Teva Pharmaceuticals International GmbH Feste formen von risdiplam und verfahren zur herstellung davon
WO2022162107A1 (en) * 2021-02-01 2022-08-04 Sandoz Ag Crystalline form of risdiplam

Also Published As

Publication number Publication date
IL324578A (en) 2026-01-01
CN121399140A (zh) 2026-01-23
WO2024236590A1 (en) 2024-11-21

Similar Documents

Publication Publication Date Title
CN102448963B (zh) 7-[(3R,4R)-3-羟基-4-羟基甲基-吡咯烷-1-基甲基]-3,5-二氢-吡咯并[3,2-d]嘧啶-4-酮的有用药学上的盐
AU2004268024A1 (en) Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
EP1654263A1 (de) Phosphorsäuresalz eines dipeptidylpeptidase-iv-inhibitors
JP2001512109A (ja) 結晶性ジベンゾチアゼピン誘導体およびその抗精神病薬としての使用
CZ289215B6 (cs) Dihydrát methansulfonátu 5-(2-(4-(1,2-benzizothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor-1,3-dihydro-2H-indol-2-onu a jeho pouľití a farmaceutická kompozice na jeho bázi
JP2017061578A (ja) 有機化合物
AU2014336747A1 (en) Crystal form of (r)-praziquantel and preparation method and application thereof
US20080058367A1 (en) Process for the purification of palonosetron or its salt
WO2022199708A1 (zh) 卢美哌隆药用盐、制备方法、含其的药物组合物及应用
CN111777595A (zh) 一种环己烷甲酰胺类化合物的新晶型及其制备方法
CN114644642B (zh) 一种噻吩并吡啶化合物的晶型a、制备方法及其药物组合物
WO2020049598A2 (en) Apalutamide polymorphs
EP4713331A1 (de) Neue kristalline form von risdiplam und herstellungsverfahren dafür
KR101743783B1 (ko) 신규 화합물
JP2007524569A (ja) ナテグリニドの結晶形
WO2022234602A1 (en) A process for the preparation of solid state forms of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl) pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl)}-n-(pyridine-2-yl)benzamide
WO2018214877A1 (zh) 一种地佐辛晶型及其制备方法
WO2019048808A1 (en) NOVEL POLYMORPHS OF DOLUTÉGRAVIR SODIQUE
EP0847400B1 (de) Polymorphs von prodrug 6-n(l-ala-l-ala)-trovafloxacin
CN114685512B (zh) 一种伊布替尼-烟酸共晶及其制备方法
CN113698420A (zh) 比克替拉韦钠的新晶型及其制备方法
US11970499B1 (en) Pyrazolo[1,5-c]pyrimidine compounds as CK2 inhibitors
EP3004101A1 (de) Kristalline form von n,n-dicyclopropyl-4-(1,5-dimethyl-1h-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-carboxamid zur behandlung myeloproliferativen erkrankungen
WO2008127618A1 (en) Crystalline and amorphous forms of naltrexone hydrochloride
WO2019127294A1 (zh) 一种纯化替格瑞洛的方法

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR